Studies Compare Various Treatments for COVID-19
Sotrovimab effective compared with molnupiravir; second study shows no effect for angiotensin receptor blockers in terms of illness severity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.